Effectiveness of Desensitisation and Pain Neuroscience Education in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain

Launched by KUTAHYA HEALTH SCIENCES UNIVERSITY · Oct 8, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how effective two treatment approaches—desensitisation and pain neuroscience education—are for patients with Carpal Tunnel Syndrome (CTS) who are experiencing a specific type of pain called nociplastic pain. Nociplastic pain occurs when the nervous system becomes more sensitive to pain signals without any obvious injury or damage. The goal of the study is to see if these treatments can help reduce pain and improve daily functioning for people with this condition.

To be eligible for the study, participants need to be diagnosed with Carpal Tunnel Syndrome and be between the ages of 18 and 65. They also need to be willing to participate. However, individuals with certain health issues, such as diabetes, previous surgeries for CTS, or other specific medical conditions, won’t be able to join. The trial is not yet recruiting participants, but once it begins, those involved can expect to learn more about their pain and how to manage it better through education and hands-on techniques. This could potentially lead to improved quality of life for those suffering from this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being diagnosed with CTS
• • Being suitable for the nosiplastic pain phenotype
• • Being between the ages of 18-65
• • Volunteering to participate in the study
• Exclusion Criteria:
• • Having systemic inflammatory disease
• • Having a disease that may cause polyneuropathy such as diabetes mellitus
• • Having a pacemaker
• • Having a disease affecting the central nervous system
• • Having cervical radiculopathy
• • History of previous operation or local steroid injection due to CTS
• • Hypersensitivity to heat and cold